Allianz Asset Management GmbH Invests $2.69 Million in American Healthcare REIT, Inc. (NYSE:AHR)

Key Points

• Allianz Asset Management GmbH made a significant investment of approximately $2.69 million in American Healthcare REIT, acquiring 88,686 shares in the 1st quarter.
• American Healthcare REIT sanctioned a quarterly dividend of $0.25, translating to an annual yield of 2.62%, despite having a notably high dividend payout ratio of -370.37%.
• Analysts are optimistic, with ten investment analysts giving the stock a "Buy" rating and a consensus target price of approximately $38.11, indicating potential growth.

Allianz Asset Management GmbH bought a new position in American Healthcare REIT, Inc. (NYSE:AHR - Free Report) during the first quarter, according to its most recent disclosure with the SEC. The institutional investor bought 88,686 shares of the company's stock, valued at approximately $2,687,000. Allianz Asset Management GmbH owned 0.06% of American Healthcare REIT at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of AHR. Vanguard Group Inc. raised its position in American Healthcare REIT by 94.8% in the 4th quarter. Vanguard Group Inc. now owns 15,357,331 shares of the company's stock worth $436,455,000 after buying an additional 7,474,374 shares during the last quarter. Geode Capital Management LLC raised its position in American Healthcare REIT by 46.4% in the 4th quarter. Geode Capital Management LLC now owns 3,699,793 shares of the company's stock worth $105,171,000 after buying an additional 1,172,670 shares during the last quarter. Northern Trust Corp raised its position in American Healthcare REIT by 99.0% in the 4th quarter. Northern Trust Corp now owns 1,732,882 shares of the company's stock worth $49,249,000 after buying an additional 861,882 shares during the last quarter. Norges Bank purchased a new position in American Healthcare REIT in the 4th quarter worth about $19,339,000. Finally, Waterfront Capital Partners LLC purchased a new position in American Healthcare REIT in the 4th quarter worth about $15,066,000. 16.68% of the stock is owned by hedge funds and other institutional investors.

American Healthcare REIT Price Performance

Shares of NYSE AHR traded up $0.26 during mid-day trading on Friday, hitting $38.90. 1,291,974 shares of the company's stock traded hands, compared to its average volume of 1,000,340. The company's 50-day moving average is $36.35 and its two-hundred day moving average is $32.29. The company has a debt-to-equity ratio of 0.45, a current ratio of 0.38 and a quick ratio of 0.38. The company has a market capitalization of $6.20 billion, a P/E ratio of -144.07, a PEG ratio of 2.18 and a beta of 1.08. American Healthcare REIT, Inc. has a 1 year low of $14.79 and a 1 year high of $39.30.

American Healthcare REIT (NYSE:AHR - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported $0.38 EPS for the quarter, topping analysts' consensus estimates of $0.37 by $0.01. The firm had revenue of $540.60 million during the quarter, compared to analysts' expectations of $542.32 million. American Healthcare REIT had a negative net margin of 1.96% and a negative return on equity of 1.85%. The firm's revenue for the quarter was up 8.2% compared to the same quarter last year. During the same period in the previous year, the company earned $0.30 EPS. On average, equities analysts anticipate that American Healthcare REIT, Inc. will post 1.41 EPS for the current fiscal year.

American Healthcare REIT Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, July 18th. Shareholders of record on Monday, June 30th were paid a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 2.6%. The ex-dividend date was Monday, June 30th. American Healthcare REIT's payout ratio is -370.37%.

Wall Street Analyst Weigh In

Several brokerages have issued reports on AHR. KeyCorp raised their target price on American Healthcare REIT from $34.00 to $40.00 and gave the stock an "overweight" rating in a research report on Wednesday, June 11th. Truist Financial raised their target price on American Healthcare REIT from $32.00 to $38.00 and gave the stock a "buy" rating in a research report on Monday, June 9th. Scotiabank began coverage on American Healthcare REIT in a research report on Monday, June 30th. They issued a "sector outperform" rating and a $42.00 target price on the stock. Morgan Stanley raised their target price on American Healthcare REIT from $37.00 to $45.00 and gave the stock an "overweight" rating in a research report on Tuesday, May 20th. Finally, Robert W. Baird began coverage on American Healthcare REIT in a research report on Friday, July 18th. They issued an "outperform" rating and a $41.00 price target for the company. Ten equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus price target of $38.11.

Insider Transactions at American Healthcare REIT

In other American Healthcare REIT news, CIO Stefan K.L. Oh sold 3,860 shares of the stock in a transaction dated Monday, June 30th. The stock was sold at an average price of $36.10, for a total value of $139,346.00. Following the completion of the sale, the executive directly owned 95,671 shares in the company, valued at approximately $3,453,723.10. This trade represents a 3.88% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.92% of the stock is owned by company insiders.

American Healthcare REIT Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.